Amivantamab vs Mobocertinib in Exon 20 NSCLC ONCOLOGY-NEW YORK Spira, A. I., Bestvina, C., Sabari, J. K., Das, M., Nagasaka, M. 2023; 37 (8): 340-342

View details for Web of Science ID 001096527200005